TGA Australia approves COVID-19 vaccine Janssen to prevent COVID-19.- Janssen Cilag Pty. Ltd.
This viral vector vaccine is provisionally approved and included in the Australian Register of Therapeutic Goods (ARTG) for the active immunisation for the prevention of coronavirus disease-2019 (COVID-19) in adults greater than or equal to 18 years of age.
The official recommendation is for this vaccine to be given in a single dose. Provisional approval of this vaccine is subject to certain strict conditions, such as the requirement for Janssen-Cilag Pty Ltd to continue providing information to the TGA on longer-term efficacy and safety from ongoing clinical trials and post-market assessment. The Janssen vaccine has been shown to prevent COVID-19; however, it is not yet known whether it prevents transmission or asymptomatic disease.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
3 mins